 TEL AVIV, Israel, April 29, 2021 GLOBE NEWSWIRE -- InspireMD, Inc. NYSE American: NSPR, developer of the CGuardTM Embolic Prevention System EPS for the prevention of the stroke caused by carotid artery disease, today announces the formation of its Scientific Advisory Board with its newly appointed chair, acclaimed interventional cardiologist, Kenneth Rosenfield, M.D. 